Four questions for you to answer, four facts you need to know.
Treatment Strategies to Limit Hypoglycemia
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
ADA 2017: Hypoglycemia and the Role of Glycemic Variability
Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.
ADA 2017: Evaluating Cardiovascular Safety of Antidiabetic Agents
Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.
ADA 2017: CV Complications of Diabetes
A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.
ADA 2017: Oral Agents Under Review
When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.
ADA 2017: Insulins go Head-to-Head
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Post-Test on T2DM Back-to-Basics Special Report
Try these 10 questions and see what you've learned during this month's special report on the nuts-and-bolts of T2DM for PCPs.
Study Finds Diabetes a Risk Factor for Excess Antibiotic Use
A large Danish study compared community antibiotic use and hospital-treated infections between people with and without type 2 diabetes.
By clicking Accept, you agree to become a member of the UBM Medica Community.